Mapping the Dose–Effect Relationship of Orbofiban from Sparse Data with an Artificial Neural Network
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 94 (11) , 2475-2486
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Abciximab pharmacodynamic model with neural networks used to integrate sources of patient variabilityClinical Pharmacology & Therapeutics, 2004
- Use of neural networks for dosage individualisation of erythropoietin in patients with secondary anemia to chronic renal failureComputers in Biology and Medicine, 2003
- Pharmacodynamic population analysis in chronic renal failure using artificial neural networks—a comparative studyNeural Networks, 2003
- Modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks.Pharmaceutical Research, 2002
- Xemilofiban/Orbofiban: Insight into Drug DevelopmentCardiovascular Drug Reviews, 2001
- Predicting Effective Drug Concentrations for Individual PatientsClinical Pharmacokinetics, 1998
- Application of Neural Networks to Population Pharmacokinetic Data AnalysisJournal of Pharmaceutical Sciences, 1997
- Artificial Neural Networks As a Novel Approach to Integrated Pharmacokinetic—Pharmacodynamic AnalysisJournal of Pharmaceutical Sciences, 1996
- Application of artificial neural networks to clinical medicineThe Lancet, 1995
- Application of Neural Networks to PharmacodynamicsJournal of Pharmaceutical Sciences, 1993